Egypt and BRICS: a new force in the pharmaceutical sector?

6 September 2023

Egypt is set to join BRICS next year as the bloc expands to include six new members, writes The Pharma Letter's Middle East and North Africa correspondent.

At the 15th BRICS Summit that was held in Johannesburg, South Africa, from 22 to 24 August 2023, the bloc announced that six new members would join founding members Brazil, Russia, India, China, and South Africa (representing a quarter of the world's wealth). These new members are Argentina, Egypt, Ethiopia, Iran, Saudi Arabia, and the United Arab of Emirates (UAE).

In fact, more than 40 countries showed interest in joining the BRICS bloc; however, only 24 countries officially requested to join and just six new nations have managed to formally join, with membership taking effect from January 1, 2024. The expanded bloc will account for some 46% of the world’s population.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK